Amicus Therapeutics (FOLD) Posts Stronger Q2 Results; Updates on Product Pipeline
Tweet Send to a Friend
Amicus Therapeutics, Inc. (Nasdaq: FOLD) reports Q2 loss of $0.41, versus ($0.60) reported for the same period a year ago.
This article: 497 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 497 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
